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Universitat Politècnica de València
Abstract
Anxiolytics (AX) are the psychotropic drugs prescribed for the treatment of anxi-
ety and insomnia for 2-4 weeks. For longer periods of consumption (>1 month) may
lead to the development of tolerance or addiction. Its prescription was 16% of the
total pharmaceutical expenditure in Spain in 2007. This paper deals with the de-
velopment of a mathematical model describing the dynamic of the addiction to AX
for the case study of the Spanish region of Castellón. The reasons believed to cause
the development of addicts to AX are: the economic situation, the marriage termi-
nation and the social contact. The simulations performed to forecast the addicts
rate for the period 2010-2014 showed an increase from 6% in 2010 to 14% in 2014
with a fluctuation about 2% between the possible economic scenarios. Finally, the
analysis of sensitivity of the rate of addicts to the fluctuation of the social contact
parameters was performed, letting us estimate its impact on the pharmaceutical
expenditure.
1 Introduction
Of all psychotropic drugs (antidepressants, antipsychotics, anxiolytics (AX)
and analgesics opioid group), the most prescribed medications are AX belon-
ging to the group of benzodiazepines [1] N05B, code defined as the classifi-
cation system Anatomical Therapeutic Chemical (ATC). The main causes of
Email address: elpopla@esp.upv.es (E. de la Pozaa).
Preprint submitted to Elsevier Science 19 September 2011
the prescription of AX by the general practitioners (GP) of Primary Health
Care Centers (PHCC) are the presence of anxiety and/or insomnia [2], [3].
The causes of the emergence of these diseases may be the presence of chronic
diseases [4], or social, economic and demographic variables [1].
In Spain, the consumption of AX has increased significantly since the 90’s. In
fact, in 2007, it represented the 16% of the total pharmaceutical expenditure.
In 2009, 15.5% of Spanish population consumed AX in a regular bases. The
public expenditure of it summed up over 200 million Euros.
These drugs are only suitable for short-term treatment (between 15-30 Defined
Daily Doses (DDD)!1 month). However, several studies show that GP often
prescribe treatments for longer, which increases the risk of patients develo-
ping tolerance and physical or psychological addiction [5]. The consequences
of developing drug dependence may lead to brain damage resulting in poor
concentration, reduced ability to react, memory loss, and accidents. It should
seek alternative therapies to psychopharmacology, to reduce not only the eco-
nomic cost, but also the social cost [6].
Also several studies have been developed in analyzing the ability of patients
who have taken sedatives for over a year to reduce and eliminate their con-
sumption [7], [8].
Recent studies show how the consumption of AX increases with the age of the
patients consumption is more common in female than in men [9], in singles,
divorced or widowed than married [10] and in situation of unemployment [11],
in general people who show lower levels of well-being. Also, the social contact
could play an important role in all levels of consumption of AX, as occurs with
other addictive behavior (nicotine, shopping, food) [12], [13]. Previous studies
[12], [13] develop discrete mathematical models considering that social contact
may spread from one person to another by the interaction of individuals [14].
The aim of this paper is to develop a mathematical model to predict addictive
behaviours to AX by social contact. For this purpose, the population of the
study is grouped into three levels according to their level of AX consumption:
incidental user, regular user and long-term user (those who have developed
addiction). This will lead us to estimate the social e!ects, the pharmaceuti-
cal expenditure, and possible public health recommendations. The paper is
organized as follows. The first section is an introduction; second develops the
mathematical model and presents the hypotheses and sources of information
considered; the third section shows the results obtained from di!erent eco-




The study population in this work is made up of subjects who were registered
as inhabitants in the Census of the province of Castellón in the Autonomous
Community of Valencia (Spain) and also were registered in the Population-
based Information System (SIP) in the province of Castellón in 2009 and
2010. The region of study was selected because of the implementation of the
electronic prescription system (RELE system) at the end of 2008. Let us note
that each inhabitant is provided a SIP number to be identified within the
National Health System.
Information about the prescription of AX at PHCC in the province of Castellón
in 2009 and 2010 was provided by the DGF (the Regional Valencian Govern-
ment’s General Pharmacy Management). Data was already codified according
to the Organic Law 15/1999 on the Protection of Personal Data.
The two databases analyzed (one from 2009, the other from 2010) consisted of
597,844 rows and 591,804 rows respectively and 5 columns embracing the code
of each person, their gender, age, number and cost of DDD of AX prescribed.
2.2 Mathematical model and hypotheses
To build the mathematical model, the population is divided into three sub-
populations according to the AX (number of DDD) prescribed by year [9]:
A: long-term users (more than 180DDD)!more than 6 months); R: regular
users (31-180DDD!2-6 months); I: incidental users (1-30 DDD)!1 month).
The subpopulation of incidental consumers (I) includes all people that have
never consumed for the period considered or they have done just occasionally.
The total population (P ) at any time n is expressed as follows:
Pn = In +Rn + An .
The dynamic of the population can be described by the following system of
di!erence equations (n, time in years):
In+1 " In = !(In + Rn + An)" d1In " "In + #1Rn + #2An " µ1InAn " $In ,
Rn+1 "Rn = "d2Rn + "In " "Rn " #1Rn + #1An + µ1InAn " µ2RnAn + $In " $Rn ,
An+1 " An = "d3An + "Rn " #1An " #2An + µ2RnAn + $Rn .
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The model was built following the assumptions of previous studies of social
contagious [12], [13]. The values of all parameters were estimated from di!erent
sources of information and hypothesis with the exception of the transit rates
(µ1, µ2) that were adjusted by the model.
The parameters of the model are:
" !, birth rate of the population, where ! = 0.00107 of Castellón for 2009
[16], according to INE (Spanish Institute of Statistics). We consider the
birth rate forecasted by INE for the period [2011,2014].
" di, mortality rate by categories of AX consumption (i=1,2,3). We used INE
information about the mortality rates by age intervals. We adjusted the
mortality rate of each category of AX to their age proportion. Let us be
d1 = 0.024038, d2 = 0.0355799, d3 = 0.0276696. [16].
" #1, rate of recovery of addictive consumers to regular consumers or transit
of regular consumers to incidental consumer through a therapy of discon-
tinuation of AX. We estimated this parameter following studies [7], [8],
[17] related to the discontinuation of AX prescription through interventions
(letter, therapy, etc) as #1 = 0.015. The recovery process is determined by
the primary action of the GP who has to diagnose the patient’s addiction
defining a therapy and secondly the patient who has to admit his illness.
" #2, rate of recovery of addictive consumers that become incidental con-
sumers after therapy (change of medication) with other substances. We
assumed that addicts aged less than 50 years old could become incidental
consumers if other medication substance di!erent from AX replaces their
AX prescription. The parameter is estimated as follows: we know from our
database that the proportion of addicts aged less than 50 years old over
the total number of addicts (26.66%), while we assume that the proportion
of addicts younger than 50 years old whose medication changes (3%). Due
to the average rate of success of the new medication (55%) [18], this way,
#2 = 0.2666# 0.03# 0.55 = 0.0043989.
" ", rate of unemployed people that consume AX. Where " = 0.0273 in
2010. This rate is considered independently of the level of consumption.
We assume that the 20% of unemployed people in Castellón (23.96% (forth
trimester 2010)) older than 35 years old (57% population of Castellón) [16])
increases the consumption of AX, becoming a regular or long-term con-
sumer. (" = 0.2# 0.2396# 0.57).
" $, rate of marriage termination (divorce, separation, annulment). As a re-
sult they develop stress and mental disorders becoming regular users and
addictive users over time [15]. It was considered constant for all categories
of consumption. $ = 0.000355. We estimated as follows: we assume that the
15% of the total employed people of Castellón in 2009 (76.04% of popula-
tion), who terminated their marriage (3.1175%; average rate in the Valen-
cian Community for the period 2006-2009 [16]) transit to a higher level of
AX consumption [15]. This way, $ = 0.7604# 0.15# 0.031175 = 0.000355.
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" µ1, transit rate of incidental consumers to regular consumers due to “social
contact” (incidental user regular user).
" µ2, transit rate of regular users to long-term consumers due to “social
contact”.(regular user addicts). We consider the social contact influence is
higher in regular consumers than in incidental ones, µ1 < µ2. It is assumed
that no consumer transits from incidental to addict consumer.
Once the parameters were estimated, and the social contact parameters µ1 and
µ2 are adjusted by the model using the data from the databases, as in [12], [13],
we forecast the consumption of AX assuming di!erent economic scenarios for
next four years (2011-2014), considering this period of time appropriate due
to the available sources of information of the parameters trying to minimize
the error of the estimations.
2.3 Economic scenarios
Di!erent simulations are developed considering that the value of " evolves
during the next four years assuming di!erent economic scenarios [19].
• Scenario L: the economic crisis will remain for at least 5 years (long-term
recovery)
• Scenario V: the economic recovery will happen in one year and half (short-
term recovery)
• Scenario $ : at first there will be a little relapse, the second year the
economic situation will su!er a recovery and then will remain constant.
• International Monetary Fund (IMF) Scenario [20]: a strong reco-
very for the first year, and then a constant recovery (unemployment rate
decreases a 1% per year) for next 4 years.
• Optimistic Scenario: the unemployment rate decreases over time.
With the aim of analyzing exclusively the social contact e!ect, we simulate
di!erent values for µ1, µ2 between the interval [1/2µ, 3/2µ], while the rest of
parameters remain constant.
3 Results
The first row of table 1 shows the composition of the population by categories
of AX consumers for 2010. The 88% of total population were incidental con-
sumers in 2010, while the long-term consumers resulted to be slightly higher
(6.22%) than the regular consumer category (5.42%). The average pharma-
ceutical expenditure of each patients’ category was: 1 Euros for the case of
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incidental consumers, 100 Euros for the regular consumer category and 643.66
Euros a long-term consumer in 2010.
The value of the parameters µ1 and µ2 were obtained: µ1 = 6.598 # 10!21
and µ2 = 6.365 # 10!6. The results obtained show how the rate of transit of
incidental to regular consumers due to their “social contact” is almost null.
The prediction shows an increase of the number of long-term consumers of AX
for all economic scenarios, (table 1). In fact, the mathematical model forecasts
about 13-14% of the total population of Castellón will be addicted to the
consumption of AX in 2014, while this subpopulation was about 6.22% in 2010.
The results between economic scenarios fluctuate about 2% in 2014. Figure 1
shows the di!erences between economic scenarios for long-term consumers.
Year Subpopulation L V $ IMF Optimistic
2010
I 522,857 522,857 522,857 522,857 522,857
R 32,112 32,112 32,112 32,112 32,112
A 36,835 36,835 36,835 36,835 36,835
2011
I 502,233 502,827 502,827 506,091 505,735
R 38,172 37,614 37,614 34,550 34,884
A 43,590 43,553 43,553 43,353 43,375
2012
I 482,753 484,448 485,019 490,773 491,127
R 40,167 38,779 38,251 33,883 33,448
A 53,269 52,969 52,926 51,576 51,654
2013
I 464,292 468,074 469,159 476,681 478,184
R 38,537 35,827 35,034 30,904 29,543
A 65,581 64,533 64,247 60,946 60,805
2014
I 446,741 453,462 453,950 463,522 466,731
R 34,204 30,235 30,404 26,725 24,358
A 79,733 77,039 76,398 70,653 69,827
Table 1
Forecast of consumers of AX by subpopulation and economic scenario.
Then, we estimated the public healthcare expenditure derived from the pre-
scription of AX for next four years and di!erent economic scenarios considering
the average expenditure for each category is constant for each year and equi-
valent to the 2010 cost. This implies we assume there is not inflation e!ect and
also there are not healthcare policies to reduce the Pharmacological Budget
(i.e. Generics use, co-payment, etc). Figure 2 shows the increasing trend of
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Fig. 1. Development of the percentage of long-term consumers of AX by economic
scenarios.
Fig. 2. Development of the Public AX expenditure for the period 2011-2014 in
Castellón.
the AX expenditure which will over double in four years, since data shows an
increase from about 23 million Euros to over 51 million Euros in 2014 in the
worst possible scenario (Scenario L) or close to 45 million Euros in the best
alternative (Optimistic Scenario).
Finally we analyze the sensitivity of the percentage of addicts to the fluc-
tuation of the social contact parameters µ1, µ2 between the interval [1/2µ,
3/2µ]. The simulations were made assuming all parameters are constant and
the rate of unemployment was estimated as the average rate of unemployment
of all possible economic scenarios considered for each year (Scenario L, V, $ ,
IMF, Optimistic). Since there are two social contact parameters µ1, µ2 with
di!erent fitting values, we will simulate each parameter µ1, µ2 considering the
other one remains constant.
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Fig. 3. Analysis of sensitivity of the number of addicts to the change of the parameter
µ2.
The sensitivity of the percentage of addicts to the oscillation of µ1, was almost
null, since the subpopulation of addicts practically remain constant for all
possible economic situation. However, as figure 3 shows, a decrease or increase
of the parameter µ2 of 50%, produces an oscillation from 10% to almost 16%
of the AX addicts rate, respectively, what would mean in economic terms a
public expenditure over 57 million Euros (3/2µ2), or 36 million Euros (µ2/2).
4 Conclusions
The paper presents a prospective model to forecast the level of consumption of
AX for the next four years (2011-2014) in the province of Castellón considering
as main variables that can influence the AX consumption: the social contact,
the economic situation, and the marital termination.
The mathematical model let us to predict the future number of regular and
addicts to AX, and as a result the volume of DDD prescribed and their public
expenditure.
Considering the demographic, economic and cultural similarities between provin-
ces, this can be applied to any Spanish province or the whole country. For the
particular case of Castellón, the percentage of consumers will double from
2010 to 2014. As consequence, the public expenditure of AX will increase for
all possible economic scenarios, measured through the rate of unemployment.
The results obtained should be considered as a valuable source of informa-
tion for Public Authorities in order to control and reduce the AX prescription
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by GP through di!erent policies, mainly alternative therapies to the phar-
macological ones since the results obtained show how the GPs’ prescribing
patterns are not in accordance with recommended dosage and duration of AX
treatment.
On the other hand, the social contact plays an important role in the deve-
lopment of addiction of AX as already other studies [12], [13] show. We have
observed an important oscillation of the percentage of addicts when the social
contact rate (µ2) fluctuates. This fact shows the relevance of the Public Au-
thorities to educate the population about the e!ects of the addiction to AX
in order to prevent the population in risk (low self-esteem) to become addicts.
Finally, as limitations of our study we could name the non-consideration of
the interaction between the variables of the model (i.e. e!ect of divorced peo-
ple is considered as a static variable and not as a dynamic; the interaction
between: mortality rate and divorce, unemployment rate and mortality, or
unemployment and birth).
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